Veterinary Vaccines Market Trends, Insights, Outlook, Industry Analysis, Demand, Business Scenario and Forecasts Report 2027

The report firstly introduced the Veterinary Vaccines basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on.

The global veterinary vaccines market is anticipated to reach value of USD 12.75 Billion by 2027, according to a current analysis by Emergen Research. The veterinary/animal vaccines market is likely to expand rapidly, due to the growing use of vaccines to treat zoonotic disorders and increasing inclination to use fewer antibiotics. Moreover, the rising rate of incidence of livestock disorders is anticipated to propel the veterinary vaccines market further during the forecast period.

Key questions answered in the report

What will be the market size in terms of value and volume in the next five years?

Which segment is currently leading the market?

In which region will the market find its highest growth?

Which players will take the lead in the market?

What are the key drivers and restraints of the market’s growth?

You Can Download Free Sample PDF Copy of Veterinary Vaccines Market at https://www.emergenresearch.com/request-sample/426

Research Methodology

Data triangulation and market breakdown

Research assumptions Research data including primary and secondary data

Primary data includes breakdown of primaries and key industry insights

Secondary data includes key data from secondary sources

Key Highlights of Report

In January 2020, Automazioni VX, Inc. entered into a cooperative agreement with Merck Animal Health, a division of Merck KGaA. The collaboration was aimed to launch Innoject Pro, a uniquely developed technology for subcutaneous injection vaccination of chicken. The technology can be utilized in conjunction with the Innovax vaccine by Merck Animal Health, which is used to safeguard poultry from bacterial infections.

The poultry segment is expected to lead the global veterinary vaccines market throughout the forecast period, expanding at a CAGR of 7.0%. The increased need for risk-free pet food, associated with a growing focus on developing new animal protection approaches, is estimated to drive the segment during the forecast period.

The injection segment is projected to retain the largest market share throughout the forecast period. Growth of the segment is attributable to increasing use of injection vaccines for protection of animal health. Injection vaccines play a crucial role in preventing and controlling the dissemination of disease outbreaks in both farm animals and livestock.

Throughout the forecast period, the inactivated segment is expected to dominate the market for veterinary vaccines. Inactivated vaccines are free from bacteria and suitable for rehabilitation, except in case of immunocompetent patients. These vaccines are usually compressed, which makes their shipping and preserving simple.

Due to growing prevalence of viral infections among livestock, including the Nipah virus infection, avian influenza, canine influenza, swine flu, and bird flu, the viral segment is expected to lead the market during the forecast period.

North America is expected to dominate the global market for veterinary vaccines during the forecast period, due to rising incidence of animal diseases and growing population of pets in the U.S.

Key market participants include Zoetis Inc., Bayer AG, Virbac SA, Merck KGaA, Eli Lilly and Company, Phibro Animal Health Corporation, Elanco Animal Health Incorporated, Aptimmune Biologics Inc., Dechra Pharmaceuticals PLC, and Laboratorios HIPRA, S.A.

Get access to FREE Sample PDF Copy of Veterinary Vaccines Market at https://www.emergenresearch.com/request-sample/426

Regional scope- North America; Europe; Asia Pacific; Central & South America; MEA

Type Outlook (Revenue, USD Billion; 2017–2027)

Poultry

Swine

Aquaculture

Cattle

Cat

Dog

Administration Path Outlook (Revenue, USD Billion; 2017–2027)

Oral

Injection

Spray/Immersion

Technology Outlook (Revenue, USD Billion; 2017–2027)

Inactivated

Live Attenuated

Recombinant

Toxoid

Infection Outlook (Revenue, USD Billion; 2017–2027)

Fungal

Bacterial

Parasitic

Viral

The industry experts have left no stone unturned to identify the major factors influencing the development rate of the Veterinary Vaccines industry including various opportunities and gaps. A thorough analysis of the micro markets with regards to the growth trends in each category makes the overall study interesting. When studying the micro markets the researchers also dig deep into their future prospect and contribution to the Veterinary Vaccines industry.

Read more@ https://www.emergenresearch.com/industry-report/veterinary-vaccines-market

Table of Content

Chapter 1. Methodology & Sources

1.1. Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Veterinary Vaccines Market Segmentation & Impact Analysis

4.1. Veterinary Vaccines Market Material Segmentation Analysis

4.2. Industrial Outlook

4.2.1. Market indicators analysis

4.2.2. Market drivers analysis

4.2.2.1. Stringent environmental regulations

4.2.2.2. Rising need to reduce bacterial or algal contamination in water systems

4.2.2.3. Increasing demand for biocides for municipal water treatment

4.2.3. Market restraints analysis

4.2.3.1. Fluctuating prices of raw material

4.2.3.2. Present challenging economic conditions due to the pandemic

4.3. Technological Insights

4.4. Regulatory Framework

4.5. Porter’s Five Forces Analysis

4.6. Competitive Metric Space Analysis

4.7. Price trend Analysis

4.8. Covid-19 Impact Analysis

Chapter 5. Veterinary Vaccines Market By Application Insights & Trends, Revenue (USD Million), Volume (Kilo Tons)

Chapter 6. Veterinary Vaccines Market By Product type Insights & Trends Revenue (USD Million), Volume (Kilo Tons)

Chapter 7. Veterinary Vaccines Market Regional Outlook

Chapter 8. Competitive Landscape

Continued…

Back to top button